| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-RISPERIDONE | 1.0MG | TABLET | Resolved | 2017-04-04 | 2017-09-08 | 5319 |
| MYLAN-RISPERIDONE | 0.50MG | TABLET | Resolved | 2017-10-23 | 2018-02-15 | 26702 |
| MYLAN-RISPERIDONE | 0.25MG | TABLET | Resolved | 2017-04-07 | 2018-02-15 | 5951 |
| MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-05-03 | 2021-11-23 | 8764 |
| MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-05-02 | 2021-11-23 | 8719 |
| MYLAN-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-03-17 | 2021-11-23 | 3346 |
| MYLAN-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-03-10 | 2021-11-23 | 206 |
| MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-03-17 | 2021-11-23 | 3360 |
| PMS-RISPERIDONE | 0.25MG | TABLET | Resolved | 2017-10-27 | 2017-12-15 | 27354 |
| PMS-RISPERIDONE | 0.25MG | TABLET | Resolved | 2017-09-08 | 2017-11-17 | 21712 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SANDOZ RISPERIDONE | 1.0MG | TABLET | Discontinued | 2021-08-19 | 2021-08-19 | 144338 |
| TEVA-RISPERIDONE | 0.25MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258711 |
| TEVA-RISPERIDONE | 4MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258688 |
| TEVA-RISPERIDONE | 3MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258685 |
| TEVA-RISPERIDONE | 2MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258679 |
| TEVA-RISPERIDONE | 1MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258673 |